Unicycive Therapeutics Inc (NASDAQ:UNCY) concluded the trading at $0.55 on Wednesday, April 03 with a rise of 0.46% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.55 and 5Y monthly beta was reading 2.252 with its price kept floating in the range of $0.5327 and $0.5905 on the day. Considering stock’s 52-week price range provides that UNCY hit a high price of $1.60 and saw its price falling to a low level of $0.20 during that period. Over a period of past 1-month, stock came adding 5.48% in its value.
In contrast, when we review UNCY stock’s current outlook then short term indicators are assigning it an average of Hold, while medium term indicators are categorizing the stock at an average of Hold. Long term indicators are suggesting an average of Hold for it.
According to ratings assigned by 2 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Unicycive Therapeutics Inc (UNCY) as a Hold, while 2 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the UNCY stock which is currently positioned at 0. It further provides that stock’s current price level is -8.36% away from its 20-day simple moving average and is -6.27% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 41.16 while volatility remained at 10.06% over the past week which changes to 9.36% when measuring it over the past month. Beta is valued at 2.15, while measure of average true range or ATR is currently at 0.05.
Having a second look at Unicycive Therapeutics Inc (NASDAQ:UNCY) provides that stock’s average daily trading volume for 3 months was 1.02 million, while it jumped to 1436180 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 113.84 million.
The percentage of outstanding shares held by the insiders is 17.08% while it is 62.01% for the institutional holders. The figures also indicate that as of 2025-03-14, number of stock’s short shares was 1.52 million which implies a short ratio of 1.93. This shows up a 157.00 of Short Interest in company’s outstanding shares on the day. In March the standing of shares short improved as it was 0.8 million in the previous month. Subtraction of -30.94% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.
